Alltracel Pharmaceuticals Plc.
Dose dependent efficacy of m.doc technology platform confirmed in preclinical trial
Published in Cardiovascular Device Liability Week, November 6th, 2005
This is the first of the current series of preclinical trials examining dosage, timing/phasing, and also combination effects with specific sterols and omega-3 fatty acids. This additional knowledge on the dose dependent efficacy, guides the planned human clinical trials concerning dosage and timing/phasing due to commence in the first quarter of 2006.
The preclinical studies; which took place in Ireland over the past 3 months...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Allgemeines Krankenhaus St. Georg, Hamburg
3-D electroanatomical mapping aids isolation of veins for treatment of atrial fibrillation - California Birth Defects Monitoring Program, Berkeley
NPPA appears to be a good candidate gene for conotruncal defects - National Research Council Canada, Ottawa
Adenoviral vector shows promise as an investigational tool when looking at neuronal damage - San Raffaele Hospital, Milan
17-beta-estradol-eluting stent was not superior to phosphorylcholine-coated stent - Whitehead Institute for Biomedical Research
Researchers offer proof-of-concept for altered nuclear transfer - Aastrom Biosciences, Inc.
Tissue repair cells used in trial for regeneration of vascular tissue in diabetic patients - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
